Skip to content

Opus Genetics IRD Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Operating margin-359.1%-87.2pp-271.9%+173pp-445.4%-24.7pp-420.7%+50.3pp-471%+93.7pp
Net margin-892.4%-543pp-349.3%+117pp-466.1%-88.2pp-377.9%+51.5pp-429.4%+94.0pp
Efficiency
Asset turnover0.2×-0.1×0.3×-0.1×0.4×0.0×0.4×+0.1×0.3×0.0×
Liquidity
Current ratio7.1×+0.7×6.4×+5.2×1.2×-0.7×1.9×-0.1×-1.3×
Per Share
Book value per share-$0.53-314%$0.25+192%$0.08-69.4%$0.28+84.2%$0.15-40.5%
Valuation
Market capitalization$307.14M+442%$138.62M+40.2%$98.85M
Price / sales25.6×+21.5×9.8×+3.0×6.8×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Opus Genetics's ratios come from?
Every ratio is computed from Opus Genetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.